000220747 001__ 220747
000220747 005__ 20180913063826.0
000220747 0247_ $$2doi$$a10.1557/mrs2009.118
000220747 022__ $$a1938-1425
000220747 037__ $$aARTICLE
000220747 245__ $$aNanopolymeric Therapeutics
000220747 260__ $$c2009
000220747 269__ $$a2009
000220747 336__ $$aJournal Articles
000220747 520__ $$aPolymers have been extensively utilized in the design of nanometer-sized delivery vehicles of chemotherapeutics for clinical cancer therapy. Polymeric nanoparticulate delivery vehicles, with chemotherapeutics being either conjugated or encapsulated, have been developed into a variety of different architectures, including polymer-drug conjugates with linear or branched polymers, micelles, and polymersomes. This review describes the progress that has been made in the field of polymeric nanomedicine that brings the science closer to clinical realization of nanopolymeric therapeutics for its application in cancer treatment.
000220747 700__ $$aTong, Rong
000220747 700__ $$aChristian, David A.
000220747 700__ $$0250159$$aTang, Li$$g270859
000220747 700__ $$aCabral, Horacio
000220747 700__ $$aBaker, James R.
000220747 700__ $$aKataoka, Kazunori
000220747 700__ $$aDischer, Dennis E.
000220747 700__ $$aCheng, Jianjun
000220747 773__ $$j34$$k06$$q422-431$$tMRS Bulletin
000220747 909C0 $$0252583$$pLBI$$xU13294
000220747 909CO $$ooai:infoscience.tind.io:220747$$pSTI$$particle
000220747 917Z8 $$x144315
000220747 917Z8 $$x144315
000220747 937__ $$aEPFL-ARTICLE-220747
000220747 973__ $$aOTHER$$rREVIEWED$$sPUBLISHED
000220747 980__ $$aARTICLE